Facebook Linkedin Twitter
Inside Precision Medicine ASCO Care Advances Report Highlights CAR-T Approvals, Other Clinical Progress Against Cancer

Drug research and development

The FDA’s embrace of precision oncology
News & Features

ASCO Care Advances Report Highlights CAR-T Approvals, Other Clinical Progress Against Cancer

Inside Precision Medicine Staff Writer -
0
Foundation Medicine says three of its comprehensive genomic profiling (CGP) assays will be used by the European Organisation for Research and Treatment of Cancer (EORTC) to inform patient eligibility for oncology clinical trials through EORTC's Screening Patients for Efficient Clinical Trial Access (SPECTA) program. [Dr. Cecil Fox (Photographer)
News & Features

Foundation Medicine Assays to Inform Eligibility for European Cancer Clinical Trials

Inside Precision Medicine Staff Writer -
0
74-Gene NGS Research Panel for Hematological Malignancies
Molecular Dx

74-Gene NGS Research Panel for Hematological Malignancies

Inside Precision Medicine Staff Writer -
0
Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule.
News & Features

First Patient Treated with Sangamo In Vivo Genome Editing Therapeutic

Inside Precision Medicine Staff Writer -
0
Business teamwork - puzzle pieces
News & Features

Cancer Genetics to Pay $12M for vivoPharm

Inside Precision Medicine Staff Writer -
0
Picture of patient receiving a dancer drug to represent precision cancer therapies
News & Features

ASCO Advocates Value Framework to Combat High Cancer Drug Prices

Inside Precision Medicine Staff Writer -
0
Little Boy with Leukemia
News & Features

Enrollment Opens in Pediatric MATCH Trial Targeting Childhood Cancers

Inside Precision Medicine Staff Writer -
0
Tumor profiling assays of Foundation Medicine and Caris Life Sciences will identify abnormalities qualifying a patient for personalized cancer treatment through NCI-MATCH. [Royalty Stock Photo/Shutterstock]
Molecular Dx

Foundation Medicine, Caris Assays Identify Patients for NCI-MATCH

Inside Precision Medicine Staff Writer -
0
The PREDICT trial will apply next-generation T-cell receptor sequencing and single-cell gene expression analysis in a study intended to find new strategies to personalize treatment for pediatric patients. (Source: © Sebastian Kaulitzki/Fotolia)
News & Features

Seattle Children’s Launches Personalized Medicine Trial Focused on IBD, GVHD

Inside Precision Medicine Staff Writer -
0
A Proper MATCH: New NGS Method Up to Snuff for Tumor Analysis in NCI-MATCH Clinical Trial
Molecular Dx

A Proper MATCH: New NGS Method Up to Snuff for Tumor Analysis in NCI-MATCH Clinical Trial

Inside Precision Medicine Staff Writer -
0
1...81828384Page 82 of 84

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine